A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
| Status: | Completed |
|---|---|
| Conditions: | Cardiology, Ocular, Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/5/2014 |
| Start Date: | August 2013 |
| End Date: | June 2014 |
| Contact: | Allergan Inc. |
| Email: | clinicaltrials@allergan.com |
This retrospective data review study will evaluate anti-VEGF injections for retinal vein
occlusion (RVO) or diabetic macular edema (DME).
occlusion (RVO) or diabetic macular edema (DME).
Inclusion Criteria:
- Macular edema in the study eye due to RVO or DME
- Received an anti-VEGF injection in the study eye on or after June 2010 for RVO and on
or after August 2012 for DME
Exclusion Criteria:
- None
We found this trial at
1
site
Click here to add this to my saved trials
